Gene description for HLA-A |
| Gene name |
major histocompatibility complex, class I, A |
| Gene symbol |
HLA-A |
| Other names/aliases |
HLAA |
| Species |
Homo sapiens |
Experiment description of studies that identified HLA-A in Serum |
| 1
|
| Experiment ID | 974 |
| Identified molecule | protein
|
| Extracellular vesicle type | Exosomes |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
22808001
|
| Organism | Homo sapiens |
| Experiment description | Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. |
| Authors | Musante L, Saraswat M, Duriez E, Byrne B, Ravidà, Domon B, Holthofer H. |
| Journal name |
PLoS One
|
| Publication year | 2012 |
| Sample | Serum |
| Sample name | Serum -Tuberculosis patient 4 |
| Isolation/purification methods | Filtration ExoQuick |
| Flotation density | - |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry |
| EV-TRACK |
EV120006: EV-METRIC:56%
|
|
|
| 2
|
| Experiment ID | 975 |
| Identified molecule | protein
|
| Extracellular vesicle type | Exosomes |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
22808001
|
| Organism | Homo sapiens |
| Experiment description | Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. |
| Authors | Musante L, Saraswat M, Duriez E, Byrne B, Ravidà, Domon B, Holthofer H. |
| Journal name |
PLoS One
|
| Publication year | 2012 |
| Sample | Serum |
| Sample name | Serum -Tuberculosis patient 5 |
| Isolation/purification methods | Filtration ExoQuick |
| Flotation density | - |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry |
| EV-TRACK |
EV120006: EV-METRIC:56%
|
|
|
| 3
|
| Experiment ID | 976 |
| Identified molecule | protein
|
| Extracellular vesicle type | Exosomes |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
22808001
|
| Organism | Homo sapiens |
| Experiment description | Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. |
| Authors | Musante L, Saraswat M, Duriez E, Byrne B, Ravidà, Domon B, Holthofer H. |
| Journal name |
PLoS One
|
| Publication year | 2012 |
| Sample | Serum |
| Sample name | Serum -Tuberculosis patient 6 |
| Isolation/purification methods | Filtration ExoQuick |
| Flotation density | - |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry |
| EV-TRACK |
EV120006: EV-METRIC:56%
|
|
|
| 4
|
| Experiment ID | 978 |
| Identified molecule | protein
|
| Extracellular vesicle type | Exosomes |
| MISEV | EVs |
| Identification method | Mass spectrometry
|
| PubMed ID |
22808001
|
| Organism | Homo sapiens |
| Experiment description | Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment. |
| Authors | Musante L, Saraswat M, Duriez E, Byrne B, Ravidà, Domon B, Holthofer H. |
| Journal name |
PLoS One
|
| Publication year | 2012 |
| Sample | Serum |
| Sample name | Serum -Tuberculosis patient 8 |
| Isolation/purification methods | Filtration ExoQuick |
| Flotation density | - |
| Molecules identified in the study | Protein |
| Methods used in the study | Mass spectrometry |
| EV-TRACK |
EV120006: EV-METRIC:56%
|
|
|
| 5
|
| Experiment ID | 2007 |
| Identified molecule | protein
|
| Extracellular vesicle type | Extracellular vesicles |
| MISEV | EVs |
| Identification method | Flow cytometry
|
| PubMed ID |
35979935
|
| Organism | Homo sapiens |
| Experiment description | Serum-derived extracellular vesicles: Novel biomarkers reflecting the disease severity of COVID-19 patients |
| Authors | Tertel T, Tomić S, Đokić J, Radojević D, Stevanović D, Ilić N, Giebel B, Kosanović M. |
| Journal name |
J Extracell Vesicles
|
| Publication year | 2022 |
| Sample | Serum |
| Sample name | Healthy donors |
| Isolation/purification methods | Differential centrifugation |
| Flotation density | - |
| Molecules identified in the study | Protein Lipid |
| Methods used in the study | Flow cytometry |
| EV-TRACK |
-
|
|
|
| 6
|
| Experiment ID | 2008 |
| Identified molecule | protein
|
| Extracellular vesicle type | Extracellular vesicles |
| MISEV | EVs |
| Identification method | Flow cytometry
|
| PubMed ID |
35979935
|
| Organism | Homo sapiens |
| Experiment description | Serum-derived extracellular vesicles: Novel biomarkers reflecting the disease severity of COVID-19 patients |
| Authors | Tertel T, Tomić S, Đokić J, Radojević D, Stevanović D, Ilić N, Giebel B, Kosanović M. |
| Journal name |
J Extracell Vesicles
|
| Publication year | 2022 |
| Sample | Serum |
| Sample name | Severe COVID-19 patients |
| Isolation/purification methods | Differential centrifugation |
| Flotation density | - |
| Molecules identified in the study | Protein Lipid |
| Methods used in the study | Flow cytometry |
| EV-TRACK |
-
|
|
|
| 7
|
| Experiment ID | 2009 |
| Identified molecule | protein
|
| Extracellular vesicle type | Extracellular vesicles |
| MISEV | EVs |
| Identification method | Flow cytometry
|
| PubMed ID |
35979935
|
| Organism | Homo sapiens |
| Experiment description | Serum-derived extracellular vesicles: Novel biomarkers reflecting the disease severity of COVID-19 patients |
| Authors | Tertel T, Tomić S, Đokić J, Radojević D, Stevanović D, Ilić N, Giebel B, Kosanović M. |
| Journal name |
J Extracell Vesicles
|
| Publication year | 2022 |
| Sample | Serum |
| Sample name | Mild COVID-19 patients |
| Isolation/purification methods | Differential centrifugation |
| Flotation density | - |
| Molecules identified in the study | Protein Lipid |
| Methods used in the study | Flow cytometry |
| EV-TRACK |
-
|
|
|